$ULBI Income Statement | Understand Stock

$ULBI

$6.36 +$0.35 (5.82%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Cost of products sold
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Intangible asset impairment
Total operating expenses
Operating (loss) income
Other expense (income):
Interest and financing expense
Miscellaneous income
Gain on litigation settlement
Total other expense, net
(Loss) income before income taxes
Income tax (benefit) provision
Net (loss) income
Net (loss) income attributable to non-controlling interest
(Loss) income attributable to Ultralife Corporation

Other comprehensive income (loss):
Foreign currency translation adjustments
Comprehensive (loss) income attributable to Ultralife Corporation
Net (loss) income per share attributable to Ultralife Corporation common stockholders – Basic (in dollars per share)
Net (loss) income per share attributable to Ultralife Corporation common stockholders – Diluted (in dollars per share)
Weighted average shares outstanding – Basic (in shares)
Weighted average shares outstanding – Diluted (in shares)

Comments